Literature DB >> 20650295

Age-related changes in magnitude and diversity of cross-reactive CD4+ T-cell responses to the novel pandemic H1N1 influenza hemagglutinin.

Ramu A Subbramanian1, Saleem Basha, Rebecca C Brady, Staci Hazenfeld, Mohamed T Shata, David I Bernstein.   

Abstract

Accumulating evidence suggests that T-cell responses play a significant role in controlling influenza disease. Although humoral responses to the major antigenic component hemagglutinin (HA) have been studied in considerable detail, our understanding of the cellular responses against this antigen is limited. Here, we systematically characterized the magnitude and diversity of immunity to pandemic H1N1 HA and its relationship to seasonal H1N1 HA responses in a cohort of healthy nonimmunized adults. We observed considerable diversity in the magnitude of crossreactive pandemic CD4+ T-cell responses among the subjects, with a subset of the individuals demonstrating higher magnitude T-cell responses against the pandemic antigen compared with the seasonal antigen. Importantly, the data suggest that age-related changes in CD4+ T-cell responses preferentially segregate to the antigenically drifting globular region of HA, more so than the conserved region involved in membrane fusion. These results have important ramifications for our understanding of influenza immunity in humans and development of vaccine strategies against this important pathogen. 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20650295     DOI: 10.1016/j.humimm.2010.07.005

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

Authors:  Yolanda D Mahnke; Areej Saqr; Staci Hazenfeld; Rebecca C Brady; Mario Roederer; Ramu A Subbramanian
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

2.  Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination.

Authors:  Dimitrios G Koutsonanos; Maria del Pilar Martin; Vladimir G Zarnitsyn; Joshy Jacob; Mark R Prausnitz; Richard W Compans; Ioanna Skountzou
Journal:  J Infect Dis       Date:  2011-06-17       Impact factor: 5.226

Review 3.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Reduced Bordetella pertussis-specific CD4+ T-Cell Responses at Older Age.

Authors:  Eleonora E Lambert; Inonge van Twillert; Lisa Beckers; Martien C M Poelen; Wanda G H Han; Daan K J Pieren; Cécile A C M van Els
Journal:  Front Aging       Date:  2022-02-02

5.  CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.

Authors:  Jennifer L Nayak; Theresa F Fitzgerald; Katherine A Richards; Hongmei Yang; John J Treanor; Andrea J Sant
Journal:  J Infect Dis       Date:  2012-11-12       Impact factor: 5.226

6.  A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.

Authors:  Glendie Marcelin; Rebecca DuBois; Adam Rubrum; Charles J Russell; Janet E McElhaney; Richard J Webby
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

7.  Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.

Authors:  Anja Scholzen; Guilhem Richard; Leonard Moise; Laurie A Baeten; Patrick M Reeves; William D Martin; Timothy A Brauns; Christine M Boyle; Susan Raju Paul; Richard Bucala; Richard A Bowen; Anja Garritsen; Anne S De Groot; Ann E Sluder; Mark C Poznansky
Journal:  Front Immunol       Date:  2019-02-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.